nodes	percent_of_prediction	percent_of_DWPC	metapath
Pantoprazole—ABCG2—Sorafenib—liver cancer	0.14	0.266	CbGbCtD
Pantoprazole—ABCG2—Doxorubicin—liver cancer	0.0852	0.161	CbGbCtD
Pantoprazole—CYP2C19—Sorafenib—liver cancer	0.0628	0.119	CbGbCtD
Pantoprazole—CYP1A2—Sorafenib—liver cancer	0.0579	0.11	CbGbCtD
Pantoprazole—CYP2C9—Sorafenib—liver cancer	0.0522	0.0987	CbGbCtD
Pantoprazole—ABCB1—Sorafenib—liver cancer	0.0507	0.0958	CbGbCtD
Pantoprazole—ABCB1—Doxorubicin—liver cancer	0.0307	0.0581	CbGbCtD
Pantoprazole—CYP3A4—Sorafenib—liver cancer	0.0304	0.0574	CbGbCtD
Pantoprazole—CYP3A4—Doxorubicin—liver cancer	0.0184	0.0348	CbGbCtD
Pantoprazole—Rabeprazole—CYP1A1—liver cancer	0.00195	0.39	CrCbGaD
Pantoprazole—Omeprazole—CYP1A1—liver cancer	0.00159	0.318	CrCbGaD
Pantoprazole—Lansoprazole—CYP1A1—liver cancer	0.00145	0.291	CrCbGaD
Pantoprazole—Dizziness—Sorafenib—liver cancer	0.000354	0.00113	CcSEcCtD
Pantoprazole—Mood swings—Doxorubicin—liver cancer	0.000352	0.00112	CcSEcCtD
Pantoprazole—Abdominal distension—Epirubicin—liver cancer	0.00035	0.00111	CcSEcCtD
Pantoprazole—Blood creatinine increased—Doxorubicin—liver cancer	0.000348	0.00111	CcSEcCtD
Pantoprazole—Dysphagia—Epirubicin—liver cancer	0.000347	0.00111	CcSEcCtD
Pantoprazole—Influenza—Epirubicin—liver cancer	0.000347	0.00111	CcSEcCtD
Pantoprazole—Asthma—Epirubicin—liver cancer	0.000347	0.00111	CcSEcCtD
Pantoprazole—Dehydration—Doxorubicin—liver cancer	0.000346	0.0011	CcSEcCtD
Pantoprazole—Eosinophilia—Epirubicin—liver cancer	0.000344	0.0011	CcSEcCtD
Pantoprazole—Liver function test abnormal—Doxorubicin—liver cancer	0.000343	0.00109	CcSEcCtD
Pantoprazole—Dry skin—Doxorubicin—liver cancer	0.000341	0.00109	CcSEcCtD
Pantoprazole—Pancreatitis—Epirubicin—liver cancer	0.000341	0.00109	CcSEcCtD
Pantoprazole—Vomiting—Sorafenib—liver cancer	0.00034	0.00108	CcSEcCtD
Pantoprazole—Abdominal pain upper—Doxorubicin—liver cancer	0.00034	0.00108	CcSEcCtD
Pantoprazole—Angina pectoris—Epirubicin—liver cancer	0.000338	0.00108	CcSEcCtD
Pantoprazole—Rash—Sorafenib—liver cancer	0.000337	0.00107	CcSEcCtD
Pantoprazole—Dermatitis—Sorafenib—liver cancer	0.000337	0.00107	CcSEcCtD
Pantoprazole—Breast disorder—Doxorubicin—liver cancer	0.000336	0.00107	CcSEcCtD
Pantoprazole—Toxic epidermal necrolysis—Doxorubicin—liver cancer	0.000335	0.00107	CcSEcCtD
Pantoprazole—Aspartate aminotransferase increased—Doxorubicin—liver cancer	0.000335	0.00107	CcSEcCtD
Pantoprazole—Headache—Sorafenib—liver cancer	0.000335	0.00107	CcSEcCtD
Pantoprazole—Bronchitis—Epirubicin—liver cancer	0.000334	0.00106	CcSEcCtD
Pantoprazole—Nasopharyngitis—Doxorubicin—liver cancer	0.000333	0.00106	CcSEcCtD
Pantoprazole—Pancytopenia—Epirubicin—liver cancer	0.00033	0.00105	CcSEcCtD
Pantoprazole—Gastritis—Doxorubicin—liver cancer	0.000329	0.00105	CcSEcCtD
Pantoprazole—Alanine aminotransferase increased—Doxorubicin—liver cancer	0.000328	0.00105	CcSEcCtD
Pantoprazole—Dysuria—Epirubicin—liver cancer	0.000325	0.00104	CcSEcCtD
Pantoprazole—Abdominal distension—Doxorubicin—liver cancer	0.000324	0.00103	CcSEcCtD
Pantoprazole—Upper respiratory tract infection—Epirubicin—liver cancer	0.000323	0.00103	CcSEcCtD
Pantoprazole—Asthma—Doxorubicin—liver cancer	0.000322	0.00102	CcSEcCtD
Pantoprazole—Dysphagia—Doxorubicin—liver cancer	0.000322	0.00102	CcSEcCtD
Pantoprazole—Influenza—Doxorubicin—liver cancer	0.000322	0.00102	CcSEcCtD
Pantoprazole—Pollakiuria—Epirubicin—liver cancer	0.000321	0.00102	CcSEcCtD
Pantoprazole—Eosinophilia—Doxorubicin—liver cancer	0.000318	0.00101	CcSEcCtD
Pantoprazole—Nausea—Sorafenib—liver cancer	0.000318	0.00101	CcSEcCtD
Pantoprazole—Photosensitivity reaction—Epirubicin—liver cancer	0.000317	0.00101	CcSEcCtD
Pantoprazole—Weight increased—Epirubicin—liver cancer	0.000316	0.00101	CcSEcCtD
Pantoprazole—Pancreatitis—Doxorubicin—liver cancer	0.000315	0.001	CcSEcCtD
Pantoprazole—Weight decreased—Epirubicin—liver cancer	0.000314	0.001	CcSEcCtD
Pantoprazole—Hyperglycaemia—Epirubicin—liver cancer	0.000313	0.000998	CcSEcCtD
Pantoprazole—Angina pectoris—Doxorubicin—liver cancer	0.000313	0.000998	CcSEcCtD
Pantoprazole—Pneumonia—Epirubicin—liver cancer	0.000312	0.000993	CcSEcCtD
Pantoprazole—Infestation NOS—Epirubicin—liver cancer	0.00031	0.000987	CcSEcCtD
Pantoprazole—Infestation—Epirubicin—liver cancer	0.00031	0.000987	CcSEcCtD
Pantoprazole—Bronchitis—Doxorubicin—liver cancer	0.000309	0.000985	CcSEcCtD
Pantoprazole—Stevens-Johnson syndrome—Epirubicin—liver cancer	0.000307	0.000978	CcSEcCtD
Pantoprazole—Pancytopenia—Doxorubicin—liver cancer	0.000305	0.000973	CcSEcCtD
Pantoprazole—Neuropathy peripheral—Epirubicin—liver cancer	0.000304	0.000967	CcSEcCtD
Pantoprazole—Jaundice—Epirubicin—liver cancer	0.000302	0.000962	CcSEcCtD
Pantoprazole—Stomatitis—Epirubicin—liver cancer	0.000302	0.000962	CcSEcCtD
Pantoprazole—Conjunctivitis—Epirubicin—liver cancer	0.000301	0.000959	CcSEcCtD
Pantoprazole—Urinary tract infection—Epirubicin—liver cancer	0.000301	0.000959	CcSEcCtD
Pantoprazole—Dysuria—Doxorubicin—liver cancer	0.000301	0.000958	CcSEcCtD
Pantoprazole—Upper respiratory tract infection—Doxorubicin—liver cancer	0.000299	0.000952	CcSEcCtD
Pantoprazole—Sweating—Epirubicin—liver cancer	0.000297	0.000946	CcSEcCtD
Pantoprazole—Pollakiuria—Doxorubicin—liver cancer	0.000297	0.000946	CcSEcCtD
Pantoprazole—Haematuria—Epirubicin—liver cancer	0.000295	0.000941	CcSEcCtD
Pantoprazole—Photosensitivity reaction—Doxorubicin—liver cancer	0.000293	0.000935	CcSEcCtD
Pantoprazole—Hepatobiliary disease—Epirubicin—liver cancer	0.000293	0.000933	CcSEcCtD
Pantoprazole—Weight increased—Doxorubicin—liver cancer	0.000293	0.000932	CcSEcCtD
Pantoprazole—Epistaxis—Epirubicin—liver cancer	0.000292	0.000931	CcSEcCtD
Pantoprazole—Weight decreased—Doxorubicin—liver cancer	0.000291	0.000927	CcSEcCtD
Pantoprazole—Sinusitis—Epirubicin—liver cancer	0.000291	0.000926	CcSEcCtD
Pantoprazole—Hyperglycaemia—Doxorubicin—liver cancer	0.00029	0.000924	CcSEcCtD
Pantoprazole—Agranulocytosis—Epirubicin—liver cancer	0.000289	0.000921	CcSEcCtD
Pantoprazole—Pneumonia—Doxorubicin—liver cancer	0.000288	0.000918	CcSEcCtD
Pantoprazole—Infestation NOS—Doxorubicin—liver cancer	0.000287	0.000913	CcSEcCtD
Pantoprazole—Infestation—Doxorubicin—liver cancer	0.000287	0.000913	CcSEcCtD
Pantoprazole—Stevens-Johnson syndrome—Doxorubicin—liver cancer	0.000284	0.000905	CcSEcCtD
Pantoprazole—Neuropathy peripheral—Doxorubicin—liver cancer	0.000281	0.000895	CcSEcCtD
Pantoprazole—Haemoglobin—Epirubicin—liver cancer	0.00028	0.00089	CcSEcCtD
Pantoprazole—Stomatitis—Doxorubicin—liver cancer	0.000279	0.00089	CcSEcCtD
Pantoprazole—Jaundice—Doxorubicin—liver cancer	0.000279	0.00089	CcSEcCtD
Pantoprazole—Rhinitis—Epirubicin—liver cancer	0.000279	0.000888	CcSEcCtD
Pantoprazole—Conjunctivitis—Doxorubicin—liver cancer	0.000279	0.000888	CcSEcCtD
Pantoprazole—Urinary tract infection—Doxorubicin—liver cancer	0.000279	0.000888	CcSEcCtD
Pantoprazole—Haemorrhage—Epirubicin—liver cancer	0.000278	0.000886	CcSEcCtD
Pantoprazole—Hepatitis—Epirubicin—liver cancer	0.000278	0.000886	CcSEcCtD
Pantoprazole—Hypoaesthesia—Epirubicin—liver cancer	0.000277	0.000882	CcSEcCtD
Pantoprazole—Pharyngitis—Epirubicin—liver cancer	0.000276	0.000879	CcSEcCtD
Pantoprazole—Sweating—Doxorubicin—liver cancer	0.000275	0.000875	CcSEcCtD
Pantoprazole—Urinary tract disorder—Epirubicin—liver cancer	0.000275	0.000875	CcSEcCtD
Pantoprazole—Oedema peripheral—Epirubicin—liver cancer	0.000274	0.000873	CcSEcCtD
Pantoprazole—Haematuria—Doxorubicin—liver cancer	0.000273	0.000871	CcSEcCtD
Pantoprazole—Connective tissue disorder—Epirubicin—liver cancer	0.000273	0.000871	CcSEcCtD
Pantoprazole—Urethral disorder—Epirubicin—liver cancer	0.000273	0.000868	CcSEcCtD
Pantoprazole—Hepatobiliary disease—Doxorubicin—liver cancer	0.000271	0.000864	CcSEcCtD
Pantoprazole—Epistaxis—Doxorubicin—liver cancer	0.00027	0.000861	CcSEcCtD
Pantoprazole—Sinusitis—Doxorubicin—liver cancer	0.000269	0.000857	CcSEcCtD
Pantoprazole—Visual impairment—Epirubicin—liver cancer	0.000268	0.000854	CcSEcCtD
Pantoprazole—Agranulocytosis—Doxorubicin—liver cancer	0.000268	0.000852	CcSEcCtD
Pantoprazole—Erythema multiforme—Epirubicin—liver cancer	0.000263	0.000838	CcSEcCtD
Pantoprazole—Eye disorder—Epirubicin—liver cancer	0.00026	0.000828	CcSEcCtD
Pantoprazole—Tinnitus—Epirubicin—liver cancer	0.000259	0.000826	CcSEcCtD
Pantoprazole—Haemoglobin—Doxorubicin—liver cancer	0.000259	0.000824	CcSEcCtD
Pantoprazole—Flushing—Epirubicin—liver cancer	0.000258	0.000822	CcSEcCtD
Pantoprazole—Rhinitis—Doxorubicin—liver cancer	0.000258	0.000822	CcSEcCtD
Pantoprazole—Haemorrhage—Doxorubicin—liver cancer	0.000257	0.00082	CcSEcCtD
Pantoprazole—Hepatitis—Doxorubicin—liver cancer	0.000257	0.00082	CcSEcCtD
Pantoprazole—Hypoaesthesia—Doxorubicin—liver cancer	0.000256	0.000816	CcSEcCtD
Pantoprazole—Pharyngitis—Doxorubicin—liver cancer	0.000255	0.000814	CcSEcCtD
Pantoprazole—Urinary tract disorder—Doxorubicin—liver cancer	0.000254	0.00081	CcSEcCtD
Pantoprazole—Oedema peripheral—Doxorubicin—liver cancer	0.000254	0.000808	CcSEcCtD
Pantoprazole—Connective tissue disorder—Doxorubicin—liver cancer	0.000253	0.000806	CcSEcCtD
Pantoprazole—Urethral disorder—Doxorubicin—liver cancer	0.000252	0.000804	CcSEcCtD
Pantoprazole—Immune system disorder—Epirubicin—liver cancer	0.000251	0.0008	CcSEcCtD
Pantoprazole—Chills—Epirubicin—liver cancer	0.00025	0.000795	CcSEcCtD
Pantoprazole—Arrhythmia—Epirubicin—liver cancer	0.000248	0.000791	CcSEcCtD
Pantoprazole—Visual impairment—Doxorubicin—liver cancer	0.000248	0.00079	CcSEcCtD
Pantoprazole—Alopecia—Epirubicin—liver cancer	0.000246	0.000783	CcSEcCtD
Pantoprazole—Mental disorder—Epirubicin—liver cancer	0.000244	0.000776	CcSEcCtD
Pantoprazole—Erythema multiforme—Doxorubicin—liver cancer	0.000243	0.000775	CcSEcCtD
Pantoprazole—Malnutrition—Epirubicin—liver cancer	0.000242	0.000771	CcSEcCtD
Pantoprazole—Eye disorder—Doxorubicin—liver cancer	0.00024	0.000766	CcSEcCtD
Pantoprazole—Tinnitus—Doxorubicin—liver cancer	0.00024	0.000764	CcSEcCtD
Pantoprazole—Flushing—Doxorubicin—liver cancer	0.000239	0.000761	CcSEcCtD
Pantoprazole—Flatulence—Epirubicin—liver cancer	0.000239	0.00076	CcSEcCtD
Pantoprazole—Tension—Epirubicin—liver cancer	0.000238	0.000757	CcSEcCtD
Pantoprazole—Dysgeusia—Epirubicin—liver cancer	0.000237	0.000755	CcSEcCtD
Pantoprazole—Nervousness—Epirubicin—liver cancer	0.000235	0.000749	CcSEcCtD
Pantoprazole—Back pain—Epirubicin—liver cancer	0.000234	0.000746	CcSEcCtD
Pantoprazole—Muscle spasms—Epirubicin—liver cancer	0.000233	0.000741	CcSEcCtD
Pantoprazole—Immune system disorder—Doxorubicin—liver cancer	0.000232	0.00074	CcSEcCtD
Pantoprazole—Chills—Doxorubicin—liver cancer	0.000231	0.000736	CcSEcCtD
Pantoprazole—Arrhythmia—Doxorubicin—liver cancer	0.00023	0.000732	CcSEcCtD
Pantoprazole—Vision blurred—Epirubicin—liver cancer	0.000228	0.000727	CcSEcCtD
Pantoprazole—Alopecia—Doxorubicin—liver cancer	0.000227	0.000724	CcSEcCtD
Pantoprazole—Mental disorder—Doxorubicin—liver cancer	0.000225	0.000718	CcSEcCtD
Pantoprazole—Ill-defined disorder—Epirubicin—liver cancer	0.000225	0.000716	CcSEcCtD
Pantoprazole—Malnutrition—Doxorubicin—liver cancer	0.000224	0.000714	CcSEcCtD
Pantoprazole—Anaemia—Epirubicin—liver cancer	0.000224	0.000713	CcSEcCtD
Pantoprazole—Agitation—Epirubicin—liver cancer	0.000222	0.000709	CcSEcCtD
Pantoprazole—Flatulence—Doxorubicin—liver cancer	0.000221	0.000703	CcSEcCtD
Pantoprazole—Tension—Doxorubicin—liver cancer	0.00022	0.0007	CcSEcCtD
Pantoprazole—Dysgeusia—Doxorubicin—liver cancer	0.000219	0.000699	CcSEcCtD
Pantoprazole—Malaise—Epirubicin—liver cancer	0.000218	0.000696	CcSEcCtD
Pantoprazole—Nervousness—Doxorubicin—liver cancer	0.000218	0.000693	CcSEcCtD
Pantoprazole—Vertigo—Epirubicin—liver cancer	0.000218	0.000693	CcSEcCtD
Pantoprazole—Syncope—Epirubicin—liver cancer	0.000217	0.000692	CcSEcCtD
Pantoprazole—Leukopenia—Epirubicin—liver cancer	0.000217	0.00069	CcSEcCtD
Pantoprazole—Back pain—Doxorubicin—liver cancer	0.000217	0.00069	CcSEcCtD
Pantoprazole—Muscle spasms—Doxorubicin—liver cancer	0.000215	0.000686	CcSEcCtD
Pantoprazole—Palpitations—Epirubicin—liver cancer	0.000214	0.000682	CcSEcCtD
Pantoprazole—Loss of consciousness—Epirubicin—liver cancer	0.000213	0.000678	CcSEcCtD
Pantoprazole—Cough—Epirubicin—liver cancer	0.000211	0.000673	CcSEcCtD
Pantoprazole—Vision blurred—Doxorubicin—liver cancer	0.000211	0.000673	CcSEcCtD
Pantoprazole—Convulsion—Epirubicin—liver cancer	0.00021	0.000668	CcSEcCtD
Pantoprazole—Hypertension—Epirubicin—liver cancer	0.000209	0.000666	CcSEcCtD
Pantoprazole—Ill-defined disorder—Doxorubicin—liver cancer	0.000208	0.000662	CcSEcCtD
Pantoprazole—Anaemia—Doxorubicin—liver cancer	0.000207	0.00066	CcSEcCtD
Pantoprazole—Chest pain—Epirubicin—liver cancer	0.000206	0.000657	CcSEcCtD
Pantoprazole—Myalgia—Epirubicin—liver cancer	0.000206	0.000657	CcSEcCtD
Pantoprazole—Arthralgia—Epirubicin—liver cancer	0.000206	0.000657	CcSEcCtD
Pantoprazole—Agitation—Doxorubicin—liver cancer	0.000206	0.000656	CcSEcCtD
Pantoprazole—Anxiety—Epirubicin—liver cancer	0.000205	0.000654	CcSEcCtD
Pantoprazole—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—liver cancer	0.000205	0.000652	CcSEcCtD
Pantoprazole—Discomfort—Epirubicin—liver cancer	0.000204	0.000649	CcSEcCtD
Pantoprazole—Malaise—Doxorubicin—liver cancer	0.000202	0.000644	CcSEcCtD
Pantoprazole—Dry mouth—Epirubicin—liver cancer	0.000202	0.000642	CcSEcCtD
Pantoprazole—Vertigo—Doxorubicin—liver cancer	0.000201	0.000641	CcSEcCtD
Pantoprazole—Syncope—Doxorubicin—liver cancer	0.000201	0.00064	CcSEcCtD
Pantoprazole—Leukopenia—Doxorubicin—liver cancer	0.000201	0.000639	CcSEcCtD
Pantoprazole—Confusional state—Epirubicin—liver cancer	0.000199	0.000635	CcSEcCtD
Pantoprazole—Palpitations—Doxorubicin—liver cancer	0.000198	0.000631	CcSEcCtD
Pantoprazole—Anaphylactic shock—Epirubicin—liver cancer	0.000198	0.000629	CcSEcCtD
Pantoprazole—Oedema—Epirubicin—liver cancer	0.000198	0.000629	CcSEcCtD
Pantoprazole—Loss of consciousness—Doxorubicin—liver cancer	0.000197	0.000627	CcSEcCtD
Pantoprazole—Infection—Epirubicin—liver cancer	0.000196	0.000625	CcSEcCtD
Pantoprazole—Cough—Doxorubicin—liver cancer	0.000195	0.000623	CcSEcCtD
Pantoprazole—Shock—Epirubicin—liver cancer	0.000194	0.000619	CcSEcCtD
Pantoprazole—Convulsion—Doxorubicin—liver cancer	0.000194	0.000618	CcSEcCtD
Pantoprazole—Nervous system disorder—Epirubicin—liver cancer	0.000194	0.000617	CcSEcCtD
Pantoprazole—Thrombocytopenia—Epirubicin—liver cancer	0.000193	0.000616	CcSEcCtD
Pantoprazole—Hypertension—Doxorubicin—liver cancer	0.000193	0.000616	CcSEcCtD
Pantoprazole—Tachycardia—Epirubicin—liver cancer	0.000193	0.000614	CcSEcCtD
Pantoprazole—Skin disorder—Epirubicin—liver cancer	0.000192	0.000611	CcSEcCtD
Pantoprazole—Hyperhidrosis—Epirubicin—liver cancer	0.000191	0.000608	CcSEcCtD
Pantoprazole—Chest pain—Doxorubicin—liver cancer	0.000191	0.000608	CcSEcCtD
Pantoprazole—Arthralgia—Doxorubicin—liver cancer	0.000191	0.000608	CcSEcCtD
Pantoprazole—Myalgia—Doxorubicin—liver cancer	0.000191	0.000608	CcSEcCtD
Pantoprazole—Anxiety—Doxorubicin—liver cancer	0.00019	0.000605	CcSEcCtD
Pantoprazole—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—liver cancer	0.000189	0.000603	CcSEcCtD
Pantoprazole—Discomfort—Doxorubicin—liver cancer	0.000188	0.0006	CcSEcCtD
Pantoprazole—Anorexia—Epirubicin—liver cancer	0.000188	0.0006	CcSEcCtD
Pantoprazole—Dry mouth—Doxorubicin—liver cancer	0.000187	0.000594	CcSEcCtD
Pantoprazole—Hypotension—Epirubicin—liver cancer	0.000185	0.000588	CcSEcCtD
Pantoprazole—Confusional state—Doxorubicin—liver cancer	0.000184	0.000587	CcSEcCtD
Pantoprazole—Anaphylactic shock—Doxorubicin—liver cancer	0.000183	0.000582	CcSEcCtD
Pantoprazole—Oedema—Doxorubicin—liver cancer	0.000183	0.000582	CcSEcCtD
Pantoprazole—Infection—Doxorubicin—liver cancer	0.000182	0.000579	CcSEcCtD
Pantoprazole—Musculoskeletal discomfort—Epirubicin—liver cancer	0.00018	0.000573	CcSEcCtD
Pantoprazole—Shock—Doxorubicin—liver cancer	0.00018	0.000573	CcSEcCtD
Pantoprazole—Nervous system disorder—Doxorubicin—liver cancer	0.000179	0.000571	CcSEcCtD
Pantoprazole—Thrombocytopenia—Doxorubicin—liver cancer	0.000179	0.00057	CcSEcCtD
Pantoprazole—Insomnia—Epirubicin—liver cancer	0.000179	0.000569	CcSEcCtD
Pantoprazole—Tachycardia—Doxorubicin—liver cancer	0.000178	0.000568	CcSEcCtD
Pantoprazole—Skin disorder—Doxorubicin—liver cancer	0.000178	0.000566	CcSEcCtD
Pantoprazole—Paraesthesia—Epirubicin—liver cancer	0.000177	0.000565	CcSEcCtD
Pantoprazole—Hyperhidrosis—Doxorubicin—liver cancer	0.000177	0.000563	CcSEcCtD
Pantoprazole—Dyspnoea—Epirubicin—liver cancer	0.000176	0.000561	CcSEcCtD
Pantoprazole—Somnolence—Epirubicin—liver cancer	0.000176	0.00056	CcSEcCtD
Pantoprazole—Anorexia—Doxorubicin—liver cancer	0.000174	0.000555	CcSEcCtD
Pantoprazole—Dyspepsia—Epirubicin—liver cancer	0.000174	0.000554	CcSEcCtD
Pantoprazole—Decreased appetite—Epirubicin—liver cancer	0.000172	0.000547	CcSEcCtD
Pantoprazole—Hypotension—Doxorubicin—liver cancer	0.000171	0.000544	CcSEcCtD
Pantoprazole—Gastrointestinal disorder—Epirubicin—liver cancer	0.000171	0.000543	CcSEcCtD
Pantoprazole—Fatigue—Epirubicin—liver cancer	0.00017	0.000543	CcSEcCtD
Pantoprazole—Pain—Epirubicin—liver cancer	0.000169	0.000538	CcSEcCtD
Pantoprazole—Constipation—Epirubicin—liver cancer	0.000169	0.000538	CcSEcCtD
Pantoprazole—Musculoskeletal discomfort—Doxorubicin—liver cancer	0.000167	0.000531	CcSEcCtD
Pantoprazole—Insomnia—Doxorubicin—liver cancer	0.000165	0.000527	CcSEcCtD
Pantoprazole—Paraesthesia—Doxorubicin—liver cancer	0.000164	0.000523	CcSEcCtD
Pantoprazole—Dyspnoea—Doxorubicin—liver cancer	0.000163	0.000519	CcSEcCtD
Pantoprazole—Feeling abnormal—Epirubicin—liver cancer	0.000163	0.000519	CcSEcCtD
Pantoprazole—Somnolence—Doxorubicin—liver cancer	0.000163	0.000518	CcSEcCtD
Pantoprazole—Gastrointestinal pain—Epirubicin—liver cancer	0.000162	0.000515	CcSEcCtD
Pantoprazole—Dyspepsia—Doxorubicin—liver cancer	0.000161	0.000513	CcSEcCtD
Pantoprazole—Decreased appetite—Doxorubicin—liver cancer	0.000159	0.000506	CcSEcCtD
Pantoprazole—Gastrointestinal disorder—Doxorubicin—liver cancer	0.000158	0.000503	CcSEcCtD
Pantoprazole—Fatigue—Doxorubicin—liver cancer	0.000158	0.000502	CcSEcCtD
Pantoprazole—Urticaria—Epirubicin—liver cancer	0.000157	0.0005	CcSEcCtD
Pantoprazole—Constipation—Doxorubicin—liver cancer	0.000156	0.000498	CcSEcCtD
Pantoprazole—Pain—Doxorubicin—liver cancer	0.000156	0.000498	CcSEcCtD
Pantoprazole—Abdominal pain—Epirubicin—liver cancer	0.000156	0.000498	CcSEcCtD
Pantoprazole—Body temperature increased—Epirubicin—liver cancer	0.000156	0.000498	CcSEcCtD
Pantoprazole—Feeling abnormal—Doxorubicin—liver cancer	0.000151	0.00048	CcSEcCtD
Pantoprazole—Gastrointestinal pain—Doxorubicin—liver cancer	0.00015	0.000476	CcSEcCtD
Pantoprazole—Hypersensitivity—Epirubicin—liver cancer	0.000146	0.000464	CcSEcCtD
Pantoprazole—Urticaria—Doxorubicin—liver cancer	0.000145	0.000463	CcSEcCtD
Pantoprazole—Abdominal pain—Doxorubicin—liver cancer	0.000145	0.00046	CcSEcCtD
Pantoprazole—Body temperature increased—Doxorubicin—liver cancer	0.000145	0.00046	CcSEcCtD
Pantoprazole—Asthenia—Epirubicin—liver cancer	0.000142	0.000452	CcSEcCtD
Pantoprazole—Pruritus—Epirubicin—liver cancer	0.00014	0.000445	CcSEcCtD
Pantoprazole—Diarrhoea—Epirubicin—liver cancer	0.000135	0.000431	CcSEcCtD
Pantoprazole—Hypersensitivity—Doxorubicin—liver cancer	0.000135	0.000429	CcSEcCtD
Pantoprazole—Asthenia—Doxorubicin—liver cancer	0.000131	0.000418	CcSEcCtD
Pantoprazole—Dizziness—Epirubicin—liver cancer	0.000131	0.000416	CcSEcCtD
Pantoprazole—Pruritus—Doxorubicin—liver cancer	0.000129	0.000412	CcSEcCtD
Pantoprazole—Vomiting—Epirubicin—liver cancer	0.000126	0.0004	CcSEcCtD
Pantoprazole—Diarrhoea—Doxorubicin—liver cancer	0.000125	0.000398	CcSEcCtD
Pantoprazole—Rash—Epirubicin—liver cancer	0.000125	0.000397	CcSEcCtD
Pantoprazole—Dermatitis—Epirubicin—liver cancer	0.000124	0.000397	CcSEcCtD
Pantoprazole—Headache—Epirubicin—liver cancer	0.000124	0.000394	CcSEcCtD
Pantoprazole—Dizziness—Doxorubicin—liver cancer	0.000121	0.000385	CcSEcCtD
Pantoprazole—Nausea—Epirubicin—liver cancer	0.000117	0.000374	CcSEcCtD
Pantoprazole—Vomiting—Doxorubicin—liver cancer	0.000116	0.00037	CcSEcCtD
Pantoprazole—Rash—Doxorubicin—liver cancer	0.000115	0.000367	CcSEcCtD
Pantoprazole—Dermatitis—Doxorubicin—liver cancer	0.000115	0.000367	CcSEcCtD
Pantoprazole—Headache—Doxorubicin—liver cancer	0.000115	0.000365	CcSEcCtD
Pantoprazole—Nausea—Doxorubicin—liver cancer	0.000109	0.000346	CcSEcCtD
Pantoprazole—SLCO1B1—Metabolism—PSMD10—liver cancer	4.02e-05	0.000264	CbGpPWpGaD
Pantoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—liver cancer	4.01e-05	0.000263	CbGpPWpGaD
Pantoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—liver cancer	3.93e-05	0.000258	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism—GOT2—liver cancer	3.91e-05	0.000257	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism of lipids and lipoproteins—GGT1—liver cancer	3.89e-05	0.000255	CbGpPWpGaD
Pantoprazole—SLCO1B1—Transmembrane transport of small molecules—ALB—liver cancer	3.83e-05	0.000252	CbGpPWpGaD
Pantoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—liver cancer	3.82e-05	0.000251	CbGpPWpGaD
Pantoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—liver cancer	3.81e-05	0.00025	CbGpPWpGaD
Pantoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—liver cancer	3.78e-05	0.000249	CbGpPWpGaD
Pantoprazole—ABCG2—Metabolism—PSMD10—liver cancer	3.72e-05	0.000244	CbGpPWpGaD
Pantoprazole—ABCG2—Metabolism—PSMA4—liver cancer	3.72e-05	0.000244	CbGpPWpGaD
Pantoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—liver cancer	3.7e-05	0.000243	CbGpPWpGaD
Pantoprazole—ABCB1—Transmembrane transport of small molecules—CYCS—liver cancer	3.68e-05	0.000241	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism—CYP2E1—liver cancer	3.68e-05	0.000241	CbGpPWpGaD
Pantoprazole—ABCG2—Metabolism—GOT2—liver cancer	3.62e-05	0.000238	CbGpPWpGaD
Pantoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—liver cancer	3.61e-05	0.000237	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—CPT1B—liver cancer	3.59e-05	0.000236	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—GLUL—liver cancer	3.59e-05	0.000236	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—UGDH—liver cancer	3.56e-05	0.000234	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	3.56e-05	0.000234	CbGpPWpGaD
Pantoprazole—ABCG2—Transmembrane transport of small molecules—ALB—liver cancer	3.55e-05	0.000233	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism of lipids and lipoproteins—GGT1—liver cancer	3.55e-05	0.000233	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—GLUL—liver cancer	3.51e-05	0.00023	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—CPT1B—liver cancer	3.51e-05	0.00023	CbGpPWpGaD
Pantoprazole—SLCO1B1—Transmembrane transport of small molecules—RAF1—liver cancer	3.47e-05	0.000228	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—NR1H4—liver cancer	3.46e-05	0.000227	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism—CYCS—liver cancer	3.44e-05	0.000226	CbGpPWpGaD
Pantoprazole—ABCG2—Metabolism—CYP2E1—liver cancer	3.41e-05	0.000224	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—GSTA3—liver cancer	3.4e-05	0.000224	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—NR1H4—liver cancer	3.38e-05	0.000222	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism—GGT1—liver cancer	3.38e-05	0.000222	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism—GOT1—liver cancer	3.38e-05	0.000222	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—EPT1—liver cancer	3.35e-05	0.00022	CbGpPWpGaD
Pantoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—liver cancer	3.33e-05	0.000219	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—GSTA3—liver cancer	3.32e-05	0.000218	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—GLUL—liver cancer	3.27e-05	0.000215	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—CPT1B—liver cancer	3.27e-05	0.000215	CbGpPWpGaD
Pantoprazole—ABCG2—Transmembrane transport of small molecules—RAF1—liver cancer	3.21e-05	0.000211	CbGpPWpGaD
Pantoprazole—ABCB1—Transmembrane transport of small molecules—HMOX1—liver cancer	3.2e-05	0.00021	CbGpPWpGaD
Pantoprazole—ABCG2—Metabolism—CYCS—liver cancer	3.19e-05	0.000209	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—TAT—liver cancer	3.18e-05	0.000209	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—NR1H4—liver cancer	3.16e-05	0.000207	CbGpPWpGaD
Pantoprazole—ABCG2—Metabolism—GOT1—liver cancer	3.13e-05	0.000205	CbGpPWpGaD
Pantoprazole—ABCG2—Metabolism—GGT1—liver cancer	3.13e-05	0.000205	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—GSTA4—liver cancer	3.11e-05	0.000204	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—GSTA3—liver cancer	3.1e-05	0.000204	CbGpPWpGaD
Pantoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—liver cancer	3.07e-05	0.000201	CbGpPWpGaD
Pantoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—liver cancer	3.06e-05	0.000201	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	3.04e-05	0.0002	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—GSTA4—liver cancer	3.04e-05	0.0002	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—GSTA2—liver cancer	3.03e-05	0.000199	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism—GSTP1—liver cancer	3.03e-05	0.000199	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism of lipids and lipoproteins—GGT1—liver cancer	3.03e-05	0.000199	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism—HMOX1—liver cancer	2.99e-05	0.000196	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—GSTA2—liver cancer	2.96e-05	0.000194	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—GSTA1—liver cancer	2.93e-05	0.000192	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—NAT2—liver cancer	2.89e-05	0.00019	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—GSTA1—liver cancer	2.86e-05	0.000188	CbGpPWpGaD
Pantoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—liver cancer	2.86e-05	0.000187	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—GSTA4—liver cancer	2.84e-05	0.000186	CbGpPWpGaD
Pantoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—liver cancer	2.83e-05	0.000186	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—NAT2—liver cancer	2.83e-05	0.000185	CbGpPWpGaD
Pantoprazole—ABCG2—Metabolism—GSTP1—liver cancer	2.81e-05	0.000184	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—CPT1B—liver cancer	2.8e-05	0.000184	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—GLUL—liver cancer	2.8e-05	0.000184	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism—GSTM1—liver cancer	2.79e-05	0.000183	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism of lipids and lipoproteins—PPARA—liver cancer	2.78e-05	0.000183	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—ALDOB—liver cancer	2.78e-05	0.000182	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	2.77e-05	0.000182	CbGpPWpGaD
Pantoprazole—ABCG2—Metabolism—HMOX1—liver cancer	2.77e-05	0.000182	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—GSTA2—liver cancer	2.77e-05	0.000182	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—ALDOB—liver cancer	2.71e-05	0.000178	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—NR1H4—liver cancer	2.7e-05	0.000177	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—GSTA1—liver cancer	2.67e-05	0.000175	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—GSTA3—liver cancer	2.65e-05	0.000174	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—CRABP1—liver cancer	2.65e-05	0.000174	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism—CYP1A1—liver cancer	2.64e-05	0.000173	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—NAT2—liver cancer	2.64e-05	0.000173	CbGpPWpGaD
Pantoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—liver cancer	2.6e-05	0.000171	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—CRABP1—liver cancer	2.58e-05	0.00017	CbGpPWpGaD
Pantoprazole—ABCB1—Transmembrane transport of small molecules—PPARA—liver cancer	2.58e-05	0.00017	CbGpPWpGaD
Pantoprazole—ABCG2—Metabolism—GSTM1—liver cancer	2.58e-05	0.000169	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—liver cancer	2.54e-05	0.000167	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—ALDOB—liver cancer	2.53e-05	0.000166	CbGpPWpGaD
Pantoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—liver cancer	2.52e-05	0.000165	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism—MTHFR—liver cancer	2.46e-05	0.000162	CbGpPWpGaD
Pantoprazole—ABCG2—Metabolism—CYP1A1—liver cancer	2.45e-05	0.000161	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—GSTA4—liver cancer	2.43e-05	0.000159	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism—PPARA—liver cancer	2.42e-05	0.000159	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—CRABP1—liver cancer	2.41e-05	0.000158	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	2.38e-05	0.000157	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	2.37e-05	0.000156	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—GSTA2—liver cancer	2.36e-05	0.000155	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—HPGDS—liver cancer	2.31e-05	0.000152	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—liver cancer	2.3e-05	0.000151	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—GSTA1—liver cancer	2.28e-05	0.00015	CbGpPWpGaD
Pantoprazole—ABCG2—Metabolism—MTHFR—liver cancer	2.28e-05	0.00015	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—HPGDS—liver cancer	2.26e-05	0.000148	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—NAT2—liver cancer	2.26e-05	0.000148	CbGpPWpGaD
Pantoprazole—ABCG2—Metabolism—PPARA—liver cancer	2.24e-05	0.000147	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	2.17e-05	0.000143	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	2.17e-05	0.000143	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—liver cancer	2.17e-05	0.000142	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—ALDOB—liver cancer	2.16e-05	0.000142	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—GLUL—liver cancer	2.16e-05	0.000142	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—CPT1B—liver cancer	2.16e-05	0.000142	CbGpPWpGaD
Pantoprazole—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—liver cancer	2.13e-05	0.00014	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—HPGDS—liver cancer	2.11e-05	0.000139	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—liver cancer	2.1e-05	0.000138	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	2.1e-05	0.000138	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—NR1H4—liver cancer	2.08e-05	0.000137	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism—PIK3CG—liver cancer	2.07e-05	0.000136	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism of lipids and lipoproteins—ALB—liver cancer	2.07e-05	0.000136	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—CRABP1—liver cancer	2.06e-05	0.000135	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—PSMD10—liver cancer	2.06e-05	0.000135	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—PSMA4—liver cancer	2.06e-05	0.000135	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—GSTA3—liver cancer	2.05e-05	0.000134	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—PSMA4—liver cancer	2.01e-05	0.000132	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—PSMD10—liver cancer	2.01e-05	0.000132	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—GOT2—liver cancer	2.01e-05	0.000132	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism—PPARG—liver cancer	2e-05	0.000131	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—GOT2—liver cancer	1.96e-05	0.000129	CbGpPWpGaD
Pantoprazole—ABCB1—Transmembrane transport of small molecules—ALB—liver cancer	1.92e-05	0.000126	CbGpPWpGaD
Pantoprazole—ABCG2—Metabolism—PIK3CG—liver cancer	1.92e-05	0.000126	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	1.91e-05	0.000125	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—CYP2E1—liver cancer	1.89e-05	0.000124	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism of lipids and lipoproteins—ALB—liver cancer	1.89e-05	0.000124	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—PSMA4—liver cancer	1.88e-05	0.000123	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—PSMD10—liver cancer	1.88e-05	0.000123	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—GSTA4—liver cancer	1.87e-05	0.000123	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	1.86e-05	0.000122	CbGpPWpGaD
Pantoprazole—ABCG2—Metabolism—PPARG—liver cancer	1.85e-05	0.000121	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—CYP2E1—liver cancer	1.84e-05	0.000121	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—GOT2—liver cancer	1.83e-05	0.00012	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	1.83e-05	0.00012	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—GSTA2—liver cancer	1.82e-05	0.00012	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism—PIK3CD—liver cancer	1.82e-05	0.000119	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—HPGDS—liver cancer	1.8e-05	0.000118	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism—ALB—liver cancer	1.8e-05	0.000118	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—liver cancer	1.79e-05	0.000118	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—CYCS—liver cancer	1.76e-05	0.000116	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—GSTA1—liver cancer	1.76e-05	0.000116	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—NAT2—liver cancer	1.74e-05	0.000114	CbGpPWpGaD
Pantoprazole—ABCB1—Transmembrane transport of small molecules—RAF1—liver cancer	1.74e-05	0.000114	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—GGT1—liver cancer	1.73e-05	0.000114	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—GOT1—liver cancer	1.73e-05	0.000114	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—CYCS—liver cancer	1.72e-05	0.000113	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—CYP2E1—liver cancer	1.72e-05	0.000113	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—GOT1—liver cancer	1.69e-05	0.000111	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—GGT1—liver cancer	1.69e-05	0.000111	CbGpPWpGaD
Pantoprazole—ABCG2—Metabolism—PIK3CD—liver cancer	1.68e-05	0.000111	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—ALDOB—liver cancer	1.67e-05	0.00011	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	1.67e-05	0.000109	CbGpPWpGaD
Pantoprazole—ABCG2—Metabolism—ALB—liver cancer	1.66e-05	0.000109	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	1.63e-05	0.000107	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism of lipids and lipoproteins—ALB—liver cancer	1.61e-05	0.000106	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—CYCS—liver cancer	1.61e-05	0.000106	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—PSMA4—liver cancer	1.61e-05	0.000106	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—PSMD10—liver cancer	1.61e-05	0.000106	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—CRABP1—liver cancer	1.59e-05	0.000105	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism—PIK3CB—liver cancer	1.59e-05	0.000104	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—GOT1—liver cancer	1.58e-05	0.000104	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—GGT1—liver cancer	1.58e-05	0.000104	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—GOT2—liver cancer	1.56e-05	0.000103	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—GSTP1—liver cancer	1.56e-05	0.000102	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—HMOX1—liver cancer	1.53e-05	0.000101	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—GSTP1—liver cancer	1.52e-05	9.97e-05	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—HMOX1—liver cancer	1.5e-05	9.83e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—CYP2E1—liver cancer	1.47e-05	9.65e-05	CbGpPWpGaD
Pantoprazole—ABCG2—Metabolism—PIK3CB—liver cancer	1.47e-05	9.64e-05	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—GSTM1—liver cancer	1.43e-05	9.39e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	1.42e-05	9.34e-05	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—GSTP1—liver cancer	1.42e-05	9.31e-05	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—HMOX1—liver cancer	1.4e-05	9.19e-05	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—GSTM1—liver cancer	1.4e-05	9.16e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—HPGDS—liver cancer	1.39e-05	9.14e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—CYCS—liver cancer	1.38e-05	9.03e-05	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—CYP1A1—liver cancer	1.36e-05	8.9e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—GGT1—liver cancer	1.35e-05	8.86e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—GOT1—liver cancer	1.35e-05	8.86e-05	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—CYP1A1—liver cancer	1.32e-05	8.69e-05	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—GSTM1—liver cancer	1.3e-05	8.56e-05	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—MTHFR—liver cancer	1.26e-05	8.3e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—PSMD10—liver cancer	1.24e-05	8.14e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—PSMA4—liver cancer	1.24e-05	8.14e-05	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—PPARA—liver cancer	1.24e-05	8.14e-05	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—CYP1A1—liver cancer	1.24e-05	8.11e-05	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—MTHFR—liver cancer	1.23e-05	8.1e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—GSTP1—liver cancer	1.21e-05	7.96e-05	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—PPARA—liver cancer	1.21e-05	7.94e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—GOT2—liver cancer	1.21e-05	7.92e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—HMOX1—liver cancer	1.2e-05	7.85e-05	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—MTHFR—liver cancer	1.15e-05	7.56e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—CYP2E1—liver cancer	1.13e-05	7.45e-05	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—PPARA—liver cancer	1.13e-05	7.42e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—GSTM1—liver cancer	1.11e-05	7.31e-05	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	1.11e-05	7.31e-05	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—PIK3CG—liver cancer	1.06e-05	6.97e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—CYCS—liver cancer	1.06e-05	6.97e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—CYP1A1—liver cancer	1.06e-05	6.93e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—GOT1—liver cancer	1.04e-05	6.84e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—GGT1—liver cancer	1.04e-05	6.84e-05	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—PIK3CG—liver cancer	1.04e-05	6.8e-05	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—PPARG—liver cancer	1.02e-05	6.73e-05	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	1.02e-05	6.67e-05	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—PPARG—liver cancer	1e-05	6.57e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—MTHFR—liver cancer	9.84e-06	6.46e-05	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—PIK3CG—liver cancer	9.68e-06	6.36e-05	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism—PIK3CA—liver cancer	9.67e-06	6.35e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—PPARA—liver cancer	9.66e-06	6.34e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—GSTP1—liver cancer	9.36e-06	6.14e-05	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—PPARG—liver cancer	9.34e-06	6.13e-05	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—PIK3CD—liver cancer	9.33e-06	6.13e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—HMOX1—liver cancer	9.23e-06	6.06e-05	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—ALB—liver cancer	9.21e-06	6.05e-05	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—PIK3CD—liver cancer	9.11e-06	5.98e-05	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—ALB—liver cancer	8.99e-06	5.9e-05	CbGpPWpGaD
Pantoprazole—ABCG2—Metabolism—PIK3CA—liver cancer	8.95e-06	5.88e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	8.68e-06	5.7e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—GSTM1—liver cancer	8.6e-06	5.64e-05	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—PIK3CD—liver cancer	8.51e-06	5.59e-05	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—ALB—liver cancer	8.4e-06	5.52e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—PIK3CG—liver cancer	8.27e-06	5.43e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—CYP1A1—liver cancer	8.15e-06	5.35e-05	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—PIK3CB—liver cancer	8.13e-06	5.34e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—PPARG—liver cancer	7.98e-06	5.24e-05	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—PIK3CB—liver cancer	7.94e-06	5.21e-05	CbGpPWpGaD
Pantoprazole—SLCO1B1—Metabolism—AKT1—liver cancer	7.9e-06	5.19e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—MTHFR—liver cancer	7.6e-06	4.99e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—PPARA—liver cancer	7.45e-06	4.89e-05	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—PIK3CB—liver cancer	7.42e-06	4.87e-05	CbGpPWpGaD
Pantoprazole—ABCG2—Metabolism—AKT1—liver cancer	7.31e-06	4.8e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—PIK3CD—liver cancer	7.27e-06	4.77e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—ALB—liver cancer	7.18e-06	4.71e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—PIK3CG—liver cancer	6.38e-06	4.19e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—PIK3CB—liver cancer	6.34e-06	4.16e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—PPARG—liver cancer	6.16e-06	4.05e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—PIK3CD—liver cancer	5.61e-06	3.68e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—ALB—liver cancer	5.54e-06	3.64e-05	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—PIK3CA—liver cancer	4.96e-06	3.26e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—PIK3CB—liver cancer	4.89e-06	3.21e-05	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—PIK3CA—liver cancer	4.84e-06	3.18e-05	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—PIK3CA—liver cancer	4.52e-06	2.97e-05	CbGpPWpGaD
Pantoprazole—CYP2C19—Metabolism—AKT1—liver cancer	4.05e-06	2.66e-05	CbGpPWpGaD
Pantoprazole—ABCB1—Metabolism—AKT1—liver cancer	3.95e-06	2.6e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—PIK3CA—liver cancer	3.86e-06	2.54e-05	CbGpPWpGaD
Pantoprazole—CYP2C9—Metabolism—AKT1—liver cancer	3.69e-06	2.43e-05	CbGpPWpGaD
Pantoprazole—CYP1A2—Metabolism—AKT1—liver cancer	3.16e-06	2.07e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—PIK3CA—liver cancer	2.98e-06	1.96e-05	CbGpPWpGaD
Pantoprazole—CYP3A4—Metabolism—AKT1—liver cancer	2.44e-06	1.6e-05	CbGpPWpGaD
